4th Quarter - Report

AMERICAN COLLEGE OF CARDIOLOGY for AMERICAN COLLEGE OF CARDIOLOGY

Firm
Client
Income
—
Expenses
$890,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare physician payment; new/alternative payment models; Medicare coverage, including coverage policies pertaining to transcatheter aortic valve replacement, transcatheter mitral valve repair, myocardial positron emission tomography (PET) and hospital payment; access to Medicare claims data; physician and hospital quality; electronic health record incentive program; clinical data registries; health care quality; medical imaging and prior authorization, including HR 3107; the Stark Law and the in-office ancillary services exception, including the Medicare Care Coordination Improvement Act (HR 2282); Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; access to and supervision of Cardiac and Pulmonary Rehabilitation (HR 3911);graduate medical education policy including HR 1763/S 348, Resident Physician Shortage Reduction Act of 2019; end of life care; oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; physician-owned hospital policy, Medicaid coverage and eligibility, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; Affordable Care Act repeal/replace/reform efforts; Ways and Means Committee Medicare extenders policy/legislation; paclitaxel mortality signal in PAD patients; cardiac CT payment.

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); White House Office; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ)

Bills named: H.R. 1763 (116th), H.R. 3107 (116th), H.R. 2282 (116th), H.R. 3911 (116th)

Health Issues HCR

Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts; medical liability reform; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; clinical data registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; the South Asian Heart Health Awareness and Research Act (HR 3131), research and scholarly communication policy; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; National Clinical Care Commission Act implementation; Senate price transparency workgroup; reduction/oversight of prior authorization and other administrative burdens (HR 3107); shared decision-making; medical isotope production and supply; digital health/FDA pre-certification; cardiomyopathy education and awareness; peripheral arterial disease (PAD) education and awareness; surprise medical bills/balance billing, including HR 3630, the No Surprises Act.

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); White House Office

Bills named: H.R. 3107 (116th), H.R. 3131 (116th), H.R. 3630 (116th)

Tobacco TOB

Tobacco use prevention and smoking cessation; FDA regulation of tobacco; Tobacco 21 legislation, electronic cigarettes and nicotine products; tobacco and electronic cigarette policy in House and Senate Appropriations, including S.1258, S. 1541, S. 655, S. 1832, H.R. 2339, and H.R. 2339

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; White House Office; Natl Institutes of Health (NIH); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 2339 (116th), S. 1832 (116th), S. 1258 (116th), S. 655 (116th), S. 1541 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.